Katsuhiko Ishihara Selected Research

Katsuhiko Ishihara Research Topics

5	Inflammation (Inflammations) 04/2023 - 08/2002
5	Arthritis (Polyarthritis) 02/2009 - 08/2002
4	Rheumatoid Arthritis 01/2012 - 08/2002
4	Autoimmune Diseases (Autoimmune Disease) 02/2009 - 08/2002
3	Splenomegaly 04/2021 - 03/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2022 - 08/2002
2	Autism Spectrum Disorder 01/2020 - 01/2015
2	Parkinson Disease (Parkinson's Disease) 01/2017 - 01/2017
1	Metabolic Bone Diseases (Osteopenia) 04/2023
1	Cherubism 04/2023
1	Necrosis 04/2023
1	Dermatitis 04/2022
1	Dyslipidemias (Dyslipidemia) 04/2022
1	Obesity 04/2022
1	Fibrosis (Cirrhosis) 01/2022
1	autosomal dominant familial Periodic fever 01/2022
1	Reperfusion Injury 01/2022
1	Fever (Fevers) 01/2022
1	Hepatitis 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Proteinuria 01/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Hemophilia A (Haemophilia) 01/2018
1	Hemorrhage 01/2018
1	Mental Disorders (Mental Disorder) 01/2015
1	Schizophrenia (Dementia Praecox) 01/2015
1	Neoplasms (Cancer) 01/2014
1	Experimental Arthritis 02/2009
1	Eosinophilia 05/2007
1	Joint Diseases (Joint Disease) 06/2006
1	Infections 09/2004
1	Acute-Phase Reaction 08/2002
1	Osteoporosis 08/2002
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 08/2002
1	Multiple Myeloma 08/2002
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2002

6	CytokinesIBA 04/2022 - 08/2002
6	Interleukin-6 (Interleukin 6)IBA 02/2009 - 08/2002
2	LipopolysaccharidesIBA 04/2023 - 01/2022
2	anti-dsDNA autoantibodyIBA 04/2021 - 01/2019
2	Cytokine Receptor gp130IBA 02/2009 - 03/2004
2	Cytokine Receptors (Cytokine Receptor)IBA 02/2009 - 10/2002
2	AntigensIBA 02/2009 - 08/2002
2	Tyrosine (L-Tyrosine)FDA Link 02/2009 - 03/2004
1	Imatinib Mesylate (Gleevec)FDA Link 04/2023
1	ChemokinesIBA 04/2022
1	Palmitic Acid (Hexadecanoic Acid)IBA 04/2022
1	LeptinIBA 04/2022
1	Apolipoproteins E (ApoE)IBA 04/2022
1	Imiquimod (Aldara)FDA LinkGeneric 04/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	sphingosine kinaseIBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	GalactosamineIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2020
1	nicotinamide-beta-ribosideIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017
1	Selegiline (E250)FDA LinkGeneric 01/2017
1	Nasal SpraysIBA 01/2015
1	Cytidine DeaminaseIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 02/2009
1	CollagenIBA 02/2009
1	Becaplermin (PDGF-BB)FDA Link 02/2009
1	Collagen Type II (Type II Collagen)IBA 02/2009
1	Rheumatoid FactorIBA 02/2009
1	Immunoglobulin E (IgE)IBA 05/2007
1	Interleukin-7 (Interleukin 7)IBA 06/2006
1	InterleukinsIBA 06/2006
1	AutoantibodiesIBA 03/2004

2	Therapeutics 01/2022 - 01/2019
1	Transplantation 01/2018